Peregrine Capital Management LLC Ocular Therapeutix, Inc Transaction History
Peregrine Capital Management LLC
- $3.08 Billion
- Q2 2025
A detailed history of Peregrine Capital Management LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Peregrine Capital Management LLC holds 861,962 shares of OCUL stock, worth $10.4 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
861,962
Previous 847,468
1.71%
Holding current value
$10.4 Million
Previous $6.21 Million
28.79%
% of portfolio
0.26%
Previous 0.22%
Shares
2 transactions
Others Institutions Holding OCUL
# of Institutions
204Shares Held
137MCall Options Held
743KPut Options Held
321K-
Deep Track Capital, LP Greenwich, CT14.3MShares$173 Million4.71% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$168 Million98.75% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$155 Million23.46% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$140 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.39MShares$102 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $933M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...